|
HY-P99110-1mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-10mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-5mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P9933-1mg
|
MedChemexpress LLC
|
Dinutuximab [CAS 1363687-32-4]
|
|
|
|
|
HY-P9933-10mg
|
MedChemexpress LLC
|
Dinutuximab [CAS 1363687-32-4]
|
|
|
|
|
HY-P9933-5mg
|
MedChemexpress LLC
|
Dinutuximab [CAS 1363687-32-4]
|
|
|
|
|
HY-P99731-1mg
|
MedChemexpress LLC
|
Milatuzumab [CAS 899796-83-9]
|
|
Cancer-programmed cell death
|
|
|
HY-P99731-10mg
|
MedChemexpress LLC
|
Milatuzumab [CAS 899796-83-9]
|
|
Cancer-programmed cell death
|
|
|
HY-P99731-5mg
|
MedChemexpress LLC
|
Milatuzumab [CAS 899796-83-9]
|
|
Cancer-programmed cell death
|
|
|
HY-D1790-1mg
|
MedChemexpress LLC
|
Vari Fluor 640 SE
|
|
|
|
|
HY-D1791-1mg
|
MedChemexpress LLC
|
Vari Fluor 750 SE
|
|
|
|
|
HY-D1792-1mg
|
MedChemexpress LLC
|
Vari Fluor 555 SE
|
|
|
|
|
HY-D1795-1mg
|
MedChemexpress LLC
|
Vari Fluor 532 SE
|
|
|
|
|
HY-D1796-1mg
|
MedChemexpress LLC
|
Vari Fluor 594 SE
|
|
|
|
|
HY-D1797-1mg
|
MedChemexpress LLC
|
Vari Fluor 660 SE
|
|
|
|
|
HY-D1798-1mg
|
MedChemexpress LLC
|
Vari Fluor 350 SE
|
|
|
|
|
HY-D1799-1mg
|
MedChemexpress LLC
|
Vari Fluor 568 SE
|
|
|
|
|
HY-D1800-1mg
|
MedChemexpress LLC
|
Vari Fluor 680 SE
|
|
|
|
|
HY-D1801-1mg
|
MedChemexpress LLC
|
Vari Fluor 488 SE
|
|
|
|
|
HY-P70771-10ug
|
MedChemexpress LLC
|
IgG4 Fc, Human (HEK293)
|
|
|
|
|
HY-P70771-50ug
|
MedChemexpress LLC
|
IgG4 Fc, Human (HEK293)
|
|
|
|
|
HY-P73441-100ug
|
MedChemexpress LLC
|
TIMP-1, Rat (HEK293)
|
|
|
|
|
HY-P73441-20ug
|
MedChemexpress LLC
|
TIMP-1, Rat (HEK293)
|
|
|
|
|
HY-P73903-100ug
|
MedChemexpress LLC
|
IgG1, Human (CHO)
|
|
|
|
|
HY-P73904-10ug
|
MedChemexpress LLC
|
IgG, Rabbit (T185A, N284S, HEK293)
|
|
|
|
